That is very important, due to the fact that the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be efficient. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (jeff brown prediction). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. This was a breakthrough practically no one saw. However it's going to have profound implications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of investment chances in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown genetic sequencer stock). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly considerably prior to going higher - tech stocks. I have actually been covering bitcoin for a long time now. One of the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mostly informing readers. However that's not the big question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown investor prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of terrific private business on the verge of hitting the public markets And I have actually been working on a new method for you to invest even prior to these business go public.
This chance has actually been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the details. Go right here to book your area totally free.
Emma Walsh here, managing editor of the Journal. Regular Journal readers understand that tech isn't our normal beat (the legacy report predictions). And when it comes to tech investing, we leave it to the specialists. Luckily, we have several such professionals in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we understand (biotech stock). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and much more. These trends are experiencing exponential growth and developing incredible chances for financiers. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. jeff brown market predictions. However regardless of what lots of readers may think, this is a pattern that's simply getting started. Even though the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (biotech stock). Losing 2 months of manufacturing and sales actually affects how lots of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million units is amazing. More notably, the hold-ups caused by the pandemic produced a lots of pent-up need. And that need is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - jeff brown genetic sequencer stock. Which's not my only 5G prediction When I have actually talked about 5G in the past, I have actually described its three various stages.
In Phase 2, 5G devices go on sale. 5G phones and other products start to reach customers. And in Stage 3, 5G services begin to be provided (legacy report prediction). That's when we start to see applications working on 5G networks. Think of things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase 3 by this summertime. This begins something of a virtuous cycle: Many individuals do not truly care about the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open up a suite of incredible applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The investment chances going forward will be huge. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And throughout that time, there were really only three business running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is effectively a greenfield opportunity.
There's room for many companies to exist in this area. jeff brown stock predictions 2021. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That's important since the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been a trial-and-error procedure. Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug therapies produced using this technology. This was among those advancements that practically no one noticed. But it's going to have extensive implications for treating disease. And, naturally, there will be lots of financial investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back maybe significantly before going higher. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin - first lady. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. jeff brown genome sequencing stock. Mass, Mutual is a 150-year-old organization. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date since February 2021, however we could not separately validate this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to choose winning technology stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an exceptional viewpoint on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a number of his best choices in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he effectively anticipated some of the most significant economic occasions of the past 20 years. Although he doesn't appear to release his choices to the general public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it ideal whenever, however Jeff Brown's accurate forecasts have earned him legions of dedicated followers. That says a lot about his ability. The Future Report is released by Brownstone Research study, a popular monetary research publisher. Brownstone Research study offers several research study services with a wide array of expertises - last week.
The company is also connected with Bonner & Partners, another well-respected research study publisher - jeff brown biotech stock pick for 2020. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the very best financial investment research has actually not been offered to private investors. It has actually been typically scheduled for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown prediction for 2021. The mission of Brownstone Research study is to make that type of proprietary research readily available to any financiers looking to acquire an edge in the markets. The objective is easy to deliver distinct and rewarding investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he also functions as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you understand even a bit about the market, you understand that he has a track record as a King Midas of sorts. artificial intelligence. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown believes S.A.V. united states. could be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two cutting-edge technologies: expert system and electrical automobiles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving cars and trucks ever. It's nothing short of the vehicle industry's Holy Grail. As you understand, electric vehicles and self-driving automobile stocks have actually been huge this year, but the Wall Street machine has actually approved hype without much tangible result. In spite of an extreme boost in competitors over the previous couple of years, Brown still believes Musk has the finest chance of putting all of it together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transport. Essentially, this technology would allow you to rent your automobile as a self-governing, self-driving taxi when you're not utilizing it. You just leave the automobile and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large piece of the profits. It sounds insane, but it could be closed than you believe.